Table 3 The physicochemical properties of the generated sequence of vaccine structures designed in this study
Epitope composition | group | Vaccine sequence | AlgPred | ccSOL (< 0.4) | PI | GRAVY | VaxiJen | homology |
|---|---|---|---|---|---|---|---|---|
Multi epitope for A. baumannii | Adjuvant+ 10 B-cell epitope+ 10 MHC-I/MHCII combined coverage epitope +Adjuvant | MSPSVRHSPSVRHEAAAKVPTPYLPVYHEYGAEALERAGFVGNDGEADIKGNDLGEGGGSYQQYDQNNGGGSTSDLITKNYGGGSEYNQVKGDLDGTGVQGAEYKQKTGGGSWQDSEHNNNKLTGGGSFTYDFNDKWGGGSGSAASARAWGGGSDGKSGAALERKTSSGDPKVDLEASDAIAGGGSSATAKPAGGGGGSAWGGNVNYFGGGSTGYGGALLWGGGSRIGNDETLSIDGKNYQQAVAGQEGGVRGKMNYENNIAGGGSAEVGTTGYGGGSDSKFKPYVLGGGSFTGDVAGTFYGGGSFVGNDGEADIKGNDLGEGGGSTSDLITKNYGGGSDSKIKPYVLHEYGAEALERAGQDSQHNNGGKDGNLTNSPELQEAAAK | NON ALLERGEN | 0.641 | 4.58 | −0.618 | 1.51 | non-homologue |